Ozempic, originally developed to manage type 2 diabetes, has gained attention for its potential to aid weight loss. The medication mimics the hormone GLP-1, which stimulates insulin release, reduces glucose production in the liver, and slows gastric emptying, leading to increased feelings of fullness. While these effects can contribute to weight loss, it's important to note that Ozempic is not FDA-approved for this purpose.
Some individuals using Ozempic for weight loss have reported significant side effects, including severe gastrointestinal issues such as nausea, vomiting, and diarrhea. These adverse reactions highlight the risks associated with off-label use of the medication. Additionally, long-term side effects may include hypoglycemia and kidney complications.